Tag: Novel

Novel communication route discovered between the SARS-CoV-2 virus and human lung cells

New research from Cleveland State University could lead to improved antiviral treatments and vaccines for COVID-19 and similar viruses. An article published this week in the American Society of Microbiology’s Journal of Virology provides significant insights into the host-virus relationship of SARS-CoV-2, the virus that causes COVID-19. The research team, led by Barsanjit Mazumder, Ph.D.,

Novel device for exploratory imaging enables about 1,000 times more access to brain tissue

Science is examining the brain’s neural activity for applications ranging from innovative therapies for brain-related injuries and disease to computational learning architectures for artificial intelligence and deep neural networks. A research team has developed a tool that lets researchers see more of a live mouse’s brain, to make discoveries that can advance research into the

Novel therapy may improve survival for patients with malignant gliomas

A novel therapy engineered by Northwestern Medicine investigators improved progression-free and overall survival for patients with newly diagnosed malignant gliomas, according to results from a recent phase I clinical trial published in The Lancet Oncology. In the study, investigators evaluated the safety of a novel therapy called NSC-CRAd-S-pk7 in patients newly diagnosed with malignant gliomas.

Novel device records, senses and manipulates ‘mini-brains’

A team of scientists, led by researchers at Northwestern University, Shirley Ryan AbilityLab and the University of Illinois at Chicago (UIC), has developed novel technology promising to increase understanding of how brains develop, and offer answers on repairing brains in the wake of neurotrauma and neurodegenerative diseases. Their research is the first to combine the

Fact Check: Novel coronavirus breeds global false claims

A deadly novel coronavirus outbreak, which has infected more than 4,500 people and spread to 15 countries since emerging in China, has also spawned many false claims on social media. Here’s a selection of misinformation debunked by AFP’s Fact Check service. Sydney food not contaminated In Australia, multiple Facebook posts shared hundreds of times claimed

Researchers uncover novel amyloidosis

A collaboration led by scientists at Tokyo University of Agriculture and Technology (TUAT), Japan, has discovered a novel amyloid protein that induces amyloidosis in rats. This new amyloid protein is known to be the lipopolysaccharide binding protein (LBP) and accumulated very frequently in the mammary gland of aged rats. Although LBP was identified as an

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

A clinical trial testing the toxicity of a KRAS inhibitor demonstrated early promising antitumor activity and few adverse side effects in patients with advanced non-small cell lung cancer harboring KRAS G12C mutation, according to research presented today at the IASLC 2019 World Conference on Lung Cancer, hosted by the International Association for the Study of

Novel treatments offer new hope for patients with autoimmune disease

Autoimmune diseases, including type 1 diabetes and multiple sclerosis, arise when the body’s immune cells attack itself. Current treatments eliminate these misfunctioning immune cells, but also destroy normal, protective immune cells, leaving patients susceptible to immune deficiency and opportunistic infections. Researchers at University of Utah Health have developed a new approach that targets the misfunctioning

Super-enhancers: novel target for pancreatic ductal adenocarcinoma

Differential H3K27AC marks were identified at enhancer regions of genes including c-MYC, MED1, OCT-4, NANOG, and SOX2 that can act as super-enhancers (SE), cluster of genes in non-cancerous, cancerous and metastatic PDAC cell lines. GZ17-6.02 affects acetylation of the genes, reduces transcription of major transcription factors, sonic hedgehog pathway proteins, and stem cell markers. Dr.

Scientists reveal novel drug-target to destroy dormant cancer cells

Research spearhead by first author Isabel Puig, Post-Doctoral Fellow of the Vall d´Hebron Institute of Oncology’s (VHIO) Stem Cells & Cancer Group, directed by Principal Investigator Héctor G. Palmer, has culminated in the discovery of a biomarker to identify dormant tumor cells (DTC), also known as slow-cycling cancer cells (SCCC), that, in their dormant state,

Novel infection fighter

Hospital-acquired infections are a serious threat to patient lives, especially with the rise of antibiotic-resistant bacteria. One drug that may prove helpful in the fight against these infections is monophosphoryl Lipid A (MPLA). MPLA stimulates the immune system to help fight off invaders like bacteria or fungi. It is already used clinically to help make

Researchers discover novel mode of neurotransmitter-based communication

Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication. The discovery, published in Nature Communications, challenges current dogma about mechanisms of signaling in the brain, and uncovers new pathways for developing therapies for disorders like epilepsy, anxiety and chronic pain. Voltage-gated potassium